Актуальность

“Save the date”: “Meeting the Experts” 3rd Edition has already been scheduled.

  • 13-05-2019

The next 27th and 28th September will take place the 3rd Edition of "Meeting the Experts", the international reproductive medicine conference organized by Instituto Bernabeu.

Читать далее

Instituto Bernabeu in Albacete addresses updates in reproductive medicine on the Master's Course in Primary Healthcare at the University of Castilla La Mancha

  • 10-05-2019

Instituto Bernabeu has participated in the first edition of the Master's Course in Primary Healthcare at the University Of Castilla La Mancha (UCLM) with an intervention on latest developments in the field of reproductive medicine. The specialist training course is aimed at general practitioners, resident doctors and nursing students and its objectives include increasing participants’ capacity to resolve most of the problems presented by patients who request appointments with their general practitioner, the most proximate level of healthcare. The Master's Course includes updates on the latest developments in terms of diagnosis and treatment in primary healthcare. It is for this reason that gynaecology and reproductive medicine play a significant role.

Читать далее

Training session on vitrification and devitrification by our Head of reproductive laboratory in IB Madrid

  • 09-05-2019

Leyre Herrero, our Head of Human Biology laboratory in Instituto Bernabeu Madrid, will lead a practical theoretical workshop this Thursday where the protocol Kitazato on vitrification and devitrification will be addressed. The training session will take place in Marbella at the HC International Hospital.

Читать далее

Instituto Bernabeu obtains Quality Clinic status on the Autonomous Community of Valencia Health Clinic Official Register

  • 06-05-2019

Instituto Bernabeu has been included as a Quality Clinic on the Autonomous Community of Valencia Official Register of Health Clinics. This means that the clinic has been included on the Autonomous Community of Valencia Register of Quality Certifications for Health Clinics, Services and Establishments. It covers, on the one hand, the ISO 9001:2015 certification that the clinic was awarded in January 2016 for ‘Provision of assisted reproduction clinic healthcare, gynaecology consultations and pregnancy control. Performing molecular biology, andrology laboratory, semen bank, oocyte bank and embryo bank activities.’ On the other, the Autonomous Community Register has added UNE-EN 179006:2013 for ‘Management of patient safety risks’, awarded in December 2015.

Читать далее

Instituto Bernabeu research selected as one of the best oral presentations at the 2nd Human Genetics Interdisciplinary Congress

  • 25-04-2019

Research that was carried out by the Genetics Unit at Instituto Bernabeu Biotech and entitled ‘Mosaic segmental aneuploidies in trophectoderm cells do not affect pregnancy rates in cycles of in vitro fertilisation (IVF)’ has been selected as one of the best oral presentations at the 2nd Human Genetics Interdisciplinary Congress held in Madrid between 3rd and 5th April 2019.

Читать далее

The Medical Co-Director of Instituto Bernabeu addresses poor ovarian response at the National Fertility Congress in Italy

  • 10-04-2019

Medical Co-Director of Instituto Bernabeu, Dr Joaquín Llácer, and Dr Paolo Cirillo participated in the 2nd National Congress of the Reproductive Medicine Foundation of Italy (PMA) held in Florence on 21st and 22nd March. Dr Llácer, an expert in poor ovarian reserve, gave a conference delivered to specialists in assisted reproduction that addressed the ‘Challenges of treating patients with poor ovarian response.’ 

Читать далее

The embryology laboratory at Instituto Bernabeu attends the Human Reproduction Refresher event held in Cuenca

  • 03-04-2019

Instituto Bernabeu participated in the 20th Human Reproduction Event held in Cuenca on 21st and 22nd March and organised by the European Fertility Institute. Reproductive medicine professionals from clinics in Madrid attended the event. The Head of the In Vitro Fertilisation (IVF) Laboratory at Instituto Bernabeu in Madrid and Instituto Bernabeu biologist, Iván Ochando, attended the event where participants discussed, debated and were updated on matters within the field of assisted human reproduction.

Читать далее

Instituto Bernabeu in Albacete addresses gynaecological ultrasound scans on the Master's Course in Primary Healthcare at the University of Castilla La Mancha

  • 01-04-2019

Instituto Bernabeu in Albacete participated in the Gynaecological Ultrasound Scan Workshop organised by the University of Castilla La Mancha within the framework of its Master's Course in Primary Healthcare. María Antonia López Rubio, a doctor at the clinic in Albacete, was responsible for teaching some of the finer details of clinical practice at Instituto Bernabeu to students on the specialist training course.

Читать далее

The Scientific Director of Instituto Bernabeu Biotech addresses the importance of genetics at the 1st Understanding Disability Scientific Event held at UMH

  • 29-03-2019

The Scientific Director of Instituto Bernabeu Biotech, Dr Belén Lledó, gave a conference entitled ‘The importance of genetics in early diagnosis’ within the framework of the 1st Scientific Event ‘Understanding Disability: the importance of early diagnosis in intellectual disability and neurodevelopmental disorders’ held at Miguel Hernández University (UMH) in Elche. The gathering was organised by the Tempe/ASPA Disability and Employability Chair at UMH. Dr José Antonio Ortiz, Head of the Molecular Biology Department at Instituto Bernabeu, was also present and moderated the lecture.

Читать далее

Doctors Llácer, Castillo and Ten selected as scientific research reviewers for the world's most important infertility congress

  • 27-03-2019

The congress sponsored by the European Society of Human Reproduction and Embryology (ESHRE) and the world’s most important gathering for experts in the field has selected three doctors from Instituto Bernabeu for the role of scientific research reviewers. The reproductive medicine clinic participates annually in this essential gathering for leading researchers in the field of fertility by presenting scientific research on infertility, genetics and embryology, amongst others. Furthermore, Medical Co-Director of Instituto Bernabeu, Dr Joaquín Llácer, is a spokesperson on the society’s committee of representatives and the Spanish specialists’ representative at ESHRE until 2020.

Читать далее

The Manager of the Embryology Unit at Instituto Bernabeu addresses ova and ovarian tissue vitrification on the Master's Course in Human Reproduction given at Complutense University

  • 12-03-2019

The Manager of the Embryology Unit at Instituto Bernabeu, Dr Jorge Ten, gave a lecture on the Master’s Course in Human Reproduction organised by Complutense University in Madrid (UCM) and the Spanish Fertility Society (SEF).

Читать далее

Instituto Bernabeu Gyneacologist addresses diagnostic guidance during the Treatment of the Sterile Partner course organised by the Spanish Society of Gynaecology and Obstetrics

  • 05-03-2019

Instituto Bernabeu's gyneacologists specialised in reproductive medicine, participated in the course on Treatment of the Sterile Partner that was held on 1st March in the Madrid headquarters of the Spanish Society of Gynaecology and Obstetrics (SEGO). The training course is for gynaecologists who are interested in reproductive medicine. It is organised by the Sterility and Infertility section at SEGO and Dr Rafael Bernabeu, Vice President of SEISEGO, addressed the issue of diagnostic guidance.

Читать далее

Instituto Bernabeu in Albacete delivers a seminar on embryology for students of Medicine at Castilla La Mancha University

  • 28-02-2019

Instituto Bernabeu in Albacete is actively involved in the community in Castilla La Mancha. Its work includes talks, workshops and courses in which staff from the reproductive medicine clinic participate. Instituto Bernabeu researchers collaborate and participate in the training courses for future specialists and they help to teach them the techniques and processes that are used in reproductive medicine.

Читать далее

At the 3rd Galician and Portuguese Event on Assisted Reproduction, Dr Joaquín Llácer addresses demeanour when dealing with patients who have a poor prognosis

  • 27-02-2019

In February, Dr Joaquín Llácer, our Medical Co-Director, participated in two events aimed at reproductive medicine specialists. On 2nd February in the 3rd Galician and Portuguese Event on Assisted Reproduction, the gynaecologist who specialises in poor ovarian response gave a presentation addressing demeanour when dealing with patients who have a poor assisted reproduction prognosis. Spanish and Portuguese specialists gathered at the event in order to address legislative challenges, the challenges faced by reproductive medicine and some of the field’s ethical debates.

Читать далее

Human Reproduction highlights Instituto Bernabeu research work that addresses the influence of mitochondrial DNA on IVF results

  • 20-02-2019

Human Reproduction, a scientific journal, has published research work carried out by Instituto Bernabeu that examines whether or not the number of mitochondrial DNA copies (mtDNA) in human embryos can affect pregnancy rates. The clinic is the first to have performed a comprehensive study of embryo mtDNA linked to IVF results analysing the quantity and quality of the mtDNA.

Читать далее

New IB Newsletter: The wait will end just the way you hoped it would. Guaranteed!

  • 13-02-2019

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Pregnancy and childbirth guarantee programme or 100% reimbursment.

Читать далее

Instituto Bernabeu studies use of a new drug in order to reduce contractions before embryo transfer in patients with elevated uterine contractility

  • 06-02-2019

Instituto Bernabeu research has looked into reducing uterine hypercontractility prior to embryo transfer and if administering Atosiban helps patients with this issue.  The results of the research work entitled ‘Treatment of uterine hypercontractility with Atosiban during embryo transfer’ were presented at the 1st National Congress of the Spanish Infertility and Sterility Society (SEISEGO).

Читать далее

Instituto Bernabeu researchers describe progress in diagnosis of a rare complication: uterine incarceration

  • 30-01-2019

Instituto Bernabeu researchers have presented experience of a clinical case that describes uterine incarceration, a very infrequent complication during pregnancy. They gave their presentation at the 1st National Congress of the Spanish Society of Gynaecology and Obstetrics (SEISEGO) that was held within the framework of the Spanish Society of Gynaecology and Obstetrics Congress (SEGO). Uterine incarceration occurs during pregnancy when the uterus becomes wedged into the pelvis. There are very few available described cases of this complex and serious condition that is difficult to diagnosis. As such, this study is a very valuable contribution towards improving our understanding of it and advising medical staff about when the symptoms arise.

Читать далее

‘The future is now.’ Dr Rafael Bernabeu addresses innovation in the field of biomedicine at the 20th Intellectual Property and Innovation Congress

  • 29-01-2019

Dr Rafael Bernabeu, Medical Director at Instituto Bernabeu, has participated in the 20th Intellectual Property and Innovation Congress. The event fosters development in various innovation-intensive industries and it is held at the University of Alicante campus in Calle San Fernando 40. The event is organised by the European Intellectual Property Institutes Network (EIPIN) and it brings together international experts from a wide range of fields of intellectual property, innovation and patents.

Читать далее

New IB Newsletter: We help you so you can help many others

  • 17-01-2019

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Rafael Bernabeu Charitable Foundation opens the call for its scholarships for university students endowed with 45.000 euros. Students of Medicine, Nursing, Biology and Biotechnology of Universities from all over the country, that have brilliant trajectories and whose family income is an obstacle to continue their studies.

Читать далее

Research by Instituto Bernabeu investigates if the choice of day for sperm retrieval has an impact on pregnancy results

  • 15-01-2019

Azoospermia is one of the causes of male sterility. In order to be able to retrieve spermatozoa in men with this condition, the man has to undergo techniques involving sperm aspiration from the epididymis or testicles, or a testicular biopsy. Although these techniques can be performed at any time and the samples can be cryopreserved for use in the future, with our patients we generally aim to synchronise the procedure with oocyte retrieval. When we do so, the procedure can be performed the day before or the same day as the ovarian puncture that is used to retrieve oocytes from the female partner. Researchers at Instituto Bernabeu carried out a study to find out which of the two days chosen for testicular spermatozoa retrieval gave the best clinical results.  The research work was presented to the 1st National Congress of the Spanish Society of Gynaecology and Obstetrics (SEISEGO) that was held within the framework of the Spanish Society of Gynaecology and Obstetrics Congress (SEGO).

Читать далее

Instituto Bernabeu carries out research to determine if the number of twin pregnancies increases following embryo biopsy

  • 09-01-2019

A team of gynaecologists, embryologists, molecular biologists and biologists at Instituto Bernabeu has carried out research to determine if there is an increased number of monozygotic twin pregnancies following transfer when an embryo biopsy during the blastocyst stage (day 5 or 6 of development) has been performed. The twins come from a single ovum or single spermatozoon and they have the same genetic make-up. Pregnancies of this kind are also linked to various perinatal complications.

Читать далее

Instituto Bernabeu studies the impact on pregnancy rates of random-start ovarian stimulation performed on oocyte donors

  • 03-01-2019

Instituto Bernabeu has presented research work analysing the clinical results obtained in an oocyte donor programme following random-start ovarian stimulation in comparison with conventional ovarian stimulation to the Sterility and Infertility Section of the Spanish Society of Gynaecology and Obstetrics (SEISEGO). Researchers at the reproductive medicine clinic discovered that there are no significant differences between the results and they highlight that this is an advantage for commencing treatment and synchronising the donor and recipient.

Читать далее

We will help you so that you can help others - 2019

  • 02-01-2019

The Rafael Bernabeu Foundation has launched the edition of its €45,000 university student scholarship programme.

Читать далее

Research carried out by Instituto Bernabeu addresses different types of ovarian stimulation for IVF and their impact on chromosomal abnormalities in the embryo

  • 26-12-2018

Embryo aneuploidies are one of the main causes of failure during in vitro fertilisation (IVF) treatment. Most of the errors that lead to embryos with chromosomal abnormalities have a maternal origin and numerous studies suggest that the mother’s age is a decisive factor. Instituto Bernabeu research work that was presented at the 1st National Congress of the Spanish Infertility and Sterility Society (SEISEGO) has gone a step further. It questions if ovarian stimulation can have an impact on embryo chromosomal abnormalities.

Читать далее

Embryo vitrification work developed by Instituto Bernabeu biologist, Rafael Sellers, included in the Spanish Society of Gynaecology and Obstetrics journal

  • 12-12-2018

The Spanish Society of Gynaecology and Obstetrics has published a master’s degree dissertation written by Instituto Bernabeu biologist, Rafael Sellers. The research work entitled ‘Clinical outcomes in elective vitrification of embryos’, was managed by the Director of the Embryology Unit, Dr Jorge Ten.

Читать далее

Instituto Bernabeu analyses the impact of the vaginal microbiome on pregnancy rates in assisted reproduction treatment patients

  • 11-12-2018

The research is part of an extensive project submitted to the 1st National Congress of the Spanish Infertility and Sterility Society

Читать далее

Eight scientific research papers developed by Instituto Bernabeu were presented at the 1st Spanish Sterility and Infertility Congress held in Valladolid

  • 05-12-2018

Instituto Bernabeu was present at the 1st Spanish Sterility and Infertility Congress (SEISEGO) that was held within the framework of the Spanish Society of Gynaecology and Obstetrics (SEGO) event. Dr Rafael Bernabeu, Medical Director of the reproductive medicine clinic, is the society’s vice president and, as a prominent expert in the field, he opened the congress by moderating the first round table debate entitled ‘Updates in the basic analysis of the sterile partner’ along with Ana Belén Rodríguez.

Читать далее

Gynaecologist Andrea Bernabeu is selected for scientific evaluation of the European Society of Human Reproduction and Embryology congress

  • 04-12-2018

Dr Andrea Bernabeu, a gynaecologist at Instituto Bernabeu, has assessed the most significant clinical data presented to the European Society of Human Reproduction and Embryology (ESHRE) congress and their importance.

Читать далее

Human Fertility mentions Instituto Bernabeu research that has discovered the genetic variants in implantation failure and recurrent pregnancy loss

  • 27-11-2018

Research is our lifeline. Each and every step is an accomplishment in prognosis for patients who have all the odds against them. In its October edition, Human Fertility, the prestigious scientific magazine mentioned research work undertaken exclusively by Instituto Bernabeu scientists that opens the doors to accelerating diagnosis in patients who have experienced implantation failure and recurrent pregnancy loss. It also helps prognosis with a view to providing early treatment for these patients.

Читать далее

ВАМ ПОМОЧЬ?